Please note: This information applies only to the Wegovy® 7.2 mg dosing schedule.
Wegovy® 7.2 mg is a higher weekly dose of semaglutide for adults who need additional weight-loss support beyond the standard Wegovy® 2.4 mg dose. It contains the same active ingredient as other Wegovy® strengths—the difference is the total weekly dose.
This guide explains:
What Wegovy® 7.2 mg is.
How Wegovy® 7.2 mg differs from Wegovy® 2.4 mg.
Who may be eligible for the higher Wegovy® dose.
How to take Wegovy® 7.2 mg safely.
What to expect when using Wegovy® 7.2 mg.
What Is Wegovy® 7.2 mg?
Wegovy® 7.2 mg is a higher-dose version of semaglutide designed for people who:
Are already established on Wegovy® 2.4 mg.
Need additional weight-loss support.
Are tolerating Wegovy® well.
It is not a new medicine, it is the same Wegovy® (semaglutide) at a higher weekly dose.
How Wegovy® 7.2 mg Is Currently Given
At launch, Wegovy® 7.2 mg is delivered as:
Three separate 2.4 mg Wegovy® injections.
Taken on the same day each week.
This temporary approach is clinically approved until the single-dose Wegovy® 7.2 mg pen becomes available.
How Effective Is Wegovy® 7.2 mg?
In the STEP UP (Semaglutide Treatment Effect in People with Obesity – Up-dose) clinical trial:
People taking Wegovy® 7.2 mg lost approximately 18.7% of their body weight.
People taking Wegovy® 2.4 mg lost approximately 15.6%.
This suggests the higher Wegovy® dose may provide additional support for some patients.
Reference: Wharton S et al. Lancet Diabetes & Endocrinology. 2025.
Who Can Move Up to Wegovy® 7.2 mg?
The Wegovy® 7.2 mg dose may be considered for adults who:
Are already using Wegovy® 2.4 mg.
Have tolerated the medication well.
Need further weight-loss support.
Your MedExpress prescriber will always determine whether moving to Wegovy® 7.2 mg is clinically appropriate.
Can I Start Wegovy® at 7.2 mg?
No. All patients must begin Wegovy® at the lowest dose (0.25 mg) and increase gradually.
This step-up approach:
Helps your body adjust.
Reduces the risk of side effects.
Improves tolerability.
Wegovy® 7.2 mg is only considered after you have stabilised on Wegovy® 2.4 mg.
Why Have I Received Three Wegovy® Pens?
At launch, Wegovy® 7.2 mg requires three 2.4 mg injections each week.
This means:
You receive three Wegovy® pens per month.
Each week, you take one dose from each pen.
One pen will not last the full month, this is expected.
This setup is intentional, safe, and clinically approved.
Do the Three Wegovy® Injections Need to Be Taken on the Same Day?
Yes. For Wegovy® 7.2 mg, you should:
Take all three injections.
On the same day.
Every week.
Spacing the injections across the week is not recommended, as this may affect safety and effectiveness.
Injection Site Guidance
When taking the three weekly injections:
Use a new needle for each injection.
You may inject into the same body area if preferred.
Leave at least 5 cm between each injection site.
Rotate injection sites each week to help reduce irritation.
What if I Miss My Wegovy® 7.2 mg Dose?
If you miss your dose:
Take it as soon as possible within 5 days.
If more than 5 days have passed, skip the missed dose and continue with your normal schedule.
Do not take extra doses to make up for a missed dose.
Is Wegovy® 7.2 mg Stronger Than Mounjaro®?
Both treatments are highly effective but work differently.
Wegovy® (semaglutide): GLP-1 receptor agonist.
Mounjaro® (tirzepatide): Dual GIP and GLP-1 receptor agonist.
In clinical trials:
Wegovy® 7.2 mg: Approximately 19% weight loss.
Mounjaro® 15 mg: Approximately 21% weight loss.
The most suitable treatment depends on your response, tolerability, and clinical assessment.
Key Takeaway
Wegovy® 7.2 mg is a higher weekly dose of semaglutide for patients who need additional support beyond Wegovy® 2.4 mg. At launch, it is administered as three 2.4 mg injections taken on the same day each week. Your MedExpress prescriber will determine whether this higher dose is appropriate for you.
If you still need help after reviewing the information above, additional assistance is available.